prazosin has been researched along with Ventricular Dysfunction in 1 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Ventricular Dysfunction: A condition in which HEART VENTRICLES exhibit impaired function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coutsos, M | 1 |
| Sala-Mercado, JA | 1 |
| Ichinose, M | 1 |
| Li, Z | 1 |
| Dawe, EJ | 1 |
| O'Leary, DS | 1 |
1 other study available for prazosin and Ventricular Dysfunction
| Article | Year |
|---|---|
Muscle metaboreflex-induced coronary vasoconstriction limits ventricular contractility during dynamic exercise in heart failure.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Coronary Circulation; Coronary Vessels; Dogs; Hear | 2013 |